CNXN
PC Connection, Inc.
CNXN's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over CNXN overall, supported by stronger valuation and stronger fundamentals.
CNXN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Strong |
CNXN's revenue, profitability and balance sheet are currently healthy, but its cash flow is under pressure.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
CNXN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 14x | $58.21 | -30% |
| Forward | 17x | $83.16 | — |
| Fair | 19x | $76.99 | -7.4% |
| Current | 21x | $83.16 | — |
| Expensive | 22x | $87.28 | +5% |
Historical ranges are pointers, not guarantees.
CNXN's PE is in its expensive range at 21x. If earnings grow as analysts expect, today's price would be 17x next year's earnings, in its cheap range.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over CNXN in the historical PE scenario, which offers more potential upside but is not a forecast.
CNXN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CNXN has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
CNXN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.76 | +18% |
| Q3 2026 | $4.05 | +25% |
| Q2 2026 | $3.78 | +15% |
| Q1 2026 | $3.44 | +4.2% |
| Q4 2025 | $3.27 | -0.6% |
| Q3 2025 | $3.23 | -5% |
| Q2 2025 | $3.28 | -2.1% |
| Q1 2025 | $3.30 | +6.1% |
| Q4 2024 | $3.29 | +4.4% |
CNXN earned $4.05 per share over the past year, up 25% from the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over CNXN on earnings, with more consistent year-over-year improvement.
CNXN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $874.3M | +23% |
| Q2 2026 | $854M | +12% |
| Q1 2026 | $721.9M | +3% |
| Q4 2025 | $702.9M | -0.8% |
| Q3 2025 | $709.1M | -2.2% |
| Q2 2025 | $759.7M | +3.2% |
| Q1 2025 | $701M | +11% |
| Q4 2024 | $708.9M | +1.8% |
CNXN's revenue has picked up after two years of holding roughly level: $874M last quarter, up 23% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.7% | +0.4 points |
| Q2 2026 | 5% | +1 points |
| Q1 2026 | 2.8% | +0.7 points |
| Q4 2025 | 3.4% | +0.2 points |
| Q3 2025 | 4.3% | +0.1 points |
| Q2 2025 | 4.1% | -0.1 points |
| Q1 2025 | 2.1% | -0.1 points |
| Q4 2024 | 3.2% | -0.8 points |
CNXN's operating margin was 4.7% last quarter, about level with the same quarter a year ago, near the top of its range since 2019.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over CNXN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over CNXN on profitability, with a higher operating margin.
CNXN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $7.6M | -88% |
| Q2 2026 | -$65.7M | -367% |
| Q1 2026 | $12.3M | +$66.4M |
| Q4 2025 | $25.2M | -0.1% |
| Q3 2025 | $62.3M | +22% |
| Q2 2025 | $24.6M | -33% |
| Q1 2025 | -$54.1M | -197% |
| Q4 2024 | $25.2M | +105% |
CNXN's free cash flow was −$21M over the past year, against $58M the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over CNXN on cash generation, producing positive trailing cash flow while its opponent burns cash.
CNXN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +102K shares |
| 1 year | -0.2% | -48K shares |
| 3 years | -3.8% | -993K shares |
| 5 years | -3.5% | -927K shares |
| Available history | -4.1% | -1.1M shares |
CNXN has 25M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $2.5M |
| Q4 2025 | $10.7M |
| Q3 2025 | $5.1M |
| Q2 2025 | $16.7M |
| Q1 2025 | $43.7M |
| Q4 2024 | $4.6M |
CNXN spent $13M buying back its own shares over the past year, down 81% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over CNXN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
CNXN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -1.7x | Net Cash |
| Q2 2025 | -1.7x | Net Cash |
| Q1 2025 | -1.6x | Net Cash |
| Q4 2024 | -1.6x | Net Cash |
| Q3 2024 | -1.5x | Net Cash |
| Q2 2024 | -1.1x | Net Cash |
| Q1 2024 | -1.3x | Net Cash |
| Q4 2023 | -1.3x | Net Cash |
CNXN has more cash than debt.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CNXN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.2 | Neutral |
| Stochastic | 33.1 | Neutral |
CNXN's weekly RSI is 54 (neutral) and its Stochastic is 33 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
CNXN PE vs Technology Sector
| Metric | CNXN | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 26% below |
| PE % | 71 | 35 | 36 pts above |
CNXN has the edge over NVDA on valuation relative to its sector.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
CNXN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $87.7 | 5.2% below |
| 20 week MA | $83.7 | 0.7% below |
| 50 week MA | $71.2 | 17% above |
| 100 week MA | $67.7 | 23% above |
| 200 week MA | $63.4 | 31% above |
CNXN has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
CNXN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.0 | $44.3 | -13% |
| 2021 | $44.3 | $44.1 | -0.3% |
| 2022 | $44.1 | $47.7 | +8.1% |
| 2023 | $47.7 | $67.2 | +41% |
| 2024 | $67.2 | $69.5 | +3.4% |
| 2025 | $69.5 | $59.7 | -14% |
| 2026 YTD | $59.7 | $83.2 | +39% |
CNXN has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.